Sec Form 13G Filing - Cheval Holdings Ltd. filing for HUMANIGEN INC (HGEN) - 2021-07-19

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C.  20549

SCHEDULE 13D

(RULE 13D - 101)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(a)

(Amendment No. 7)*

(Name of Issuer)

(Title of Class of Securities)

(CUSIP Number)

Eric S. Wagner, Esq.

Kleinberg, Kaplan, Wolff & Cohen, P.C.

500 Fifth Avenue, New York, New York 10110

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box [ ].

Note:  Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.  See Rule 13d-7 for other parties to whom copies are to be sent.

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

The following constitutes Amendment No. 7 (“Amendment No. 7”) to the Schedule 13D dated July 11, 2013 filed by the Reporting Persons with respect to the shares of common stock, par value $0.001 (the “Shares”), of Humanigen, Inc. (the “Issuer”), as previously amended (the “Schedule 13D”). This Amendment No. 7 amends the Schedule 13D as specifically set forth herein.

A total of approximately $17,278,810 was paid to acquire the Shares reported as beneficially owned by the Reporting Persons.  The funds used to purchase these securities were obtained from the general working capital of the Domestic Fund, the Offshore Fund and Cheval and margin account borrowings made in the ordinary course of business, although the Reporting Persons cannot determine whether any funds allocated to purchase such securities were obtained from any margin account borrowings.

Sub-clause (a) of Item 5 is hereby amended and restated in its entirety as follows:

“(a)            The aggregate percentage of Shares reported owned by each person named herein is based upon 59,083,706 Shares outstanding as of May 5, 2021, as reported in the Issuer’s Form 10-Q filed with the Securities and Exchange Commission on May 13, 2021.

As of the date hereof, the Domestic Fund may be deemed to beneficially own 910,686 Shares, the Offshore Fund may be deemed to beneficially own 2,079,344 Shares and Cheval may be deemed to beneficially own 7,623,898 Shares, constituting approximately 1.5%, 3.5% and 12.9%, respectively, of the outstanding Shares.

BH Management, by virtue of its relationships with Domestic Fund and Cheval discussed in further detail in Item 2, may be deemed to beneficially own the 8,534,584 Shares beneficially owned by the Domestic Fund and Cheval, constituting approximately 14.4% of the outstanding Shares.

Mr. Chappell, by virtue of his relationships with the Domestic Fund, the Offshore Fund and Cheval discussed in further detail in Item 2 of the Schedule 13D, may be deemed to beneficially own the 10,613,928 Shares collectively owned by the Domestic Fund, the Offshore Fund and Cheval.  Mr. Chappell also personally owns options that are exercisable within the next 60 days for 33,440 Shares. Together, this constitutes approximately 18.0% of the outstanding Shares.”

Sub-clause (c) is hereby amended and restated in its entirety as follows:

The transactions effected by the Reporting Persons during the past 60 days that were not previously reported on Schedule 13D are set forth on Schedule B attached hereto.”

SIGNATURES

After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information with respect to it set forth in this statement is true, complete, and correct.

Dated:  July 19, 2021

Class of Security	Amount of Securities Purchased/(Sold)	Price	Reporting Person	Date of Transaction
Common Shares	(16,444)	$17.2764	Black Horse Capital LP	06/30/2021
Common Shares	(10,575)	$17.0979	Black Horse Capital LP	07/1/2021
Common Shares	(7,714)	$17.12	Black Horse Capital LP	07/2/2021
Common Shares	(3,601)	$17.1654	Black Horse Capital LP	07/08/2021
Common Shares	(22,203)	$17.3721	Black Horse Capital LP	07/09/2021
Common Shares	(1,138)	$17.0552	Black Horse Capital LP	07/14/2021
Common Shares	(43,851)	$17.2764	Black Horse Capital Master Fund Ltd.	06/30/2021
Common Shares	(28,198)	$17.0979	Black Horse Capital Master Fund Ltd.	07/1/2021
Common Shares	(20,569)	$17.12	Black Horse Capital Master Fund Ltd.	07/2/2021
Common Shares	(9,602)	$17.1654	Black Horse Capital Master Fund Ltd.	07/08/2021
Common Shares	(59,207)	$17.3721	Black Horse Capital Master Fund Ltd.	07/09/2021
Common Shares	(3,036)	$17.0552	Black Horse Capital Master Fund Ltd.	07/14/2021
Common Shares	(158,961)	$17.2764	Cheval Holdings, Ltd.	06/30/2021
Common Shares	(102,219)	$17.0979	Cheval Holdings, Ltd.	07/1/2021
Common Shares	(74,565)	$17.12	Cheval Holdings, Ltd.	07/2/2021
Common Shares	(34,807)	$17.1654	Cheval Holdings, Ltd.	07/08/2021
Common Shares	(214,626)	$17.3721	Cheval Holdings, Ltd.	07/09/2021
Common Shares	(11,003)	$17.0552	Cheval Holdings, Ltd.	07/14/2021

---